KORU Medical Systems, Inc. (KRMD) Stock

KORU Medical Systems, Inc. (KRMD) is a Healthcare stock trading at $3.27 (as of 2026-08-20), with a market capitalization of $150.98M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices for the ambulatory infusion market in the United States and internationally, including its FREEDOM mechanical infusion systems (such as syringe drivers), HIgH-Flo subcutaneous safety needle sets, and precision flow-rate tubing. The company also provides clinician, patient, and patient-advocate education and training materials, and sells through direct sales, distributors, and online.

Understand KORU Medical Systems, Inc.: how it makes money

KORU Medical Systems designs, manufactures, and markets portable infusion devices for the ambulatory infusion market, and it generates revenue by selling its FREEDOM infusion systems (including syringe drivers) and related products such as safety needle sets and flow rate tubing through direct sales and medical device distributors (and online).

Because KORU sells infusion systems and related administration products, its results are structurally driven by ongoing patient usage, so trends in its patient base and annual infusion activity should map to demand and revenue.

Revenue by segment (latest quarter)
Domestic Core	$0.0B
International Core	$0.0B

Business quality (Weak): The quarter shows very small reported revenue (rounded to 0.0B), segment values are tiny, and profitability is weak (operating margin is negative), so you should focus on the operating usage metrics and patient-driven indicators.

Bull case

Patient usage scale indicator is provided, with 45,000 Freedom System Patients Served and 45,000 Chronic and Recurring Patients: This points to a business model anchored in recurring clinical use rather than one-time procedures.
Reported clinical preference for its Freedom Edge infusion system is high (Ninety-Seven Percent of Nurses Preferred Freedom Edge Infusion System): Strong user preference can support sustained adoption in ambulatory infusion workflows.

Bear case

Operating margin is negative in the latest quarter (operating margin pct is -7.4): The company is not converting current gross profit into operating profit, which can pressure cash burn and reinvestment.
Reported revenue is extremely small in the dataset (revenue_b is 0.0B), while segment figures are also near zero: This makes performance sensitive to small changes in sales timing, orders, and product mix.
International core revenue is reported as 0.0B in the provided segment candidates: If international expansion is slow, growth may rely heavily on domestic demand.

Valuation — source: SEC EDGAR (first-party)
Price	$3.27
Market Cap	$150.98M
Price / Book	8.36
Price / Sales	3.28
FCF Yield	-0.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$41.13M
Net Margin	-6.4%
Revenue Growth (YoY)	22.2%
EPS Growth (YoY)	-53.8%
FCF Growth (YoY)	-70.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	8.18 (safe)

Valuation vs Sector & Industry
Sector P/E (Healthcare)	21.6
Industry P/E (Medical Equipment)	32.9

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	First Light Asset Management, LLC ($16.28M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Linda Tharby
Employees	80
Country	US
IPO Date	1994-04-05

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.